| Current management of overactive bladder. | |
| | |
MedLine Citation:
|
PMID: 18797274 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: The concept of overactive bladder has helped us address the problem of urgency and urge incontinence from a symptomatic perspective. In this review, we provide a critical summary of clinically relevant recent publications, focusing in particular on advances in our understanding of assessment methods and therapeutic interventions for overactive bladder in women. RECENT FINDINGS: According to current definitions, the prevalence of overactive bladder in western nations is now estimated as 13.0%. Although the prevalence increases with age, the symptoms of overactive bladder may follow a relapsing and remitting course. There has been a proliferation of validated symptom and quality of life measures and increasing sophistication in the analysis of bladder diaries. The role of urodynamics in the evaluation of urgency remains uncertain, with many trials showing limited benefit as a preoperative investigation. Fluid restriction and bladder retraining remain important first-line interventions. Many new anticholinergic medications have been licensed, with limited benefits compared with existing preparations. Intravesical botulinum toxin has become a popular alternative for patients who fail oral therapies. SUMMARY: Although there have been few important therapeutic innovations, recent publications have led to greater sophistication in assessment methods and a clearer understanding of the role of existing interventions. |
| | |
Authors:
|
Rufus Cartwright; Arasee Renganathan; Linda Cardozo |
Related Documents
:
|
10633764 - Patient selection and education for use of the capsure (re/stor) continence shield. 19951214 - Risk factors for female urinary incontinence among middle-aged korean women. 12621134 - Urinary incontinence after vaginal delivery or cesarean section. 3897584 - Delayed diagnosis of voiding dysfunction: occult spinal dysraphism. 21726894 - Promoter methylation analysis of wnt/β-catenin signaling pathway regulators to detect ... 23297124 - How do partners find out about the risk of huntington's disease in couple relationships? |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current opinion in obstetrics & gynecology Volume: 20 ISSN: 1473-656X ISO Abbreviation: Curr. Opin. Obstet. Gynecol. Publication Date: 2008 Oct |
Date Detail:
|
Created Date: 2008-09-17 Completed Date: 2009-02-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9007264 Medline TA: Curr Opin Obstet Gynecol Country: England |
Other Details:
|
Languages: eng Pagination: 489-95 Citation Subset: IM |
Affiliation:
|
Department of Urogynaecology, King's College Hospital, Denmark Hill, London, UK. rufus.cartwright@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Botulinum Toxins
/
toxicity Cholinergic Antagonists / therapeutic use Clinical Trials as Topic Female Humans Prevalence Quality of Life Urinary Bladder / pathology Urinary Bladder Diseases / drug therapy Urinary Bladder, Overactive / drug therapy*, epidemiology* Urinary Incontinence, Urge / drug therapy Urodynamics Urology / methods* |
| Chemical | |
Reg. No./Substance:
|
0/Botulinum Toxins; 0/Cholinergic Antagonists |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Uterosacral ligament vaginal vault suspension: anatomy, outcome and surgical considerations.
Next Document: An update on the laparoscopic approach to urogynecology and pelvic reconstructive procedures.